Literature DB >> 10364832

Heparinoids: structure, biological activities and therapeutic applications.

N S Gunay1, R J Linhardt.   

Abstract

Heparin is an important polyanionic drug having a wide variety of different biological activities. Substantial research effort has focused on the preparation of improved heparins and heparin analogues that might exhibit higher specificity and decreased side effects. These heparin analogues or heparinoids include sulfated polysaccharides from plant and animal origin, synthetic derivatives of polysaccharides, and acidic oligosaccharides and their small synthetic analogues. The structure, biological activities and therapeutic potential of these heparinoids are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364832     DOI: 10.1055/s-1999-13990

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

1.  In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis.

Authors:  Mei-Zhen Chen; Hao-Gui Xie; La-Wei Yang; Zao-Hui Liao; Jie Yu
Journal:  Virol Sin       Date:  2010-10-08       Impact factor: 4.327

2.  Identification of a novel structure in heparin generated by potassium permanganate oxidation.

Authors:  Daniela Beccati; Sucharita Roy; Fei Yu; Nur Sibel Gunay; Ishan Capila; Miroslaw Lech; Robert J Linhardt; Ganesh Venkataraman
Journal:  Carbohydr Polym       Date:  2010-10-15       Impact factor: 9.381

3.  Effect of 6-O-sulfonate hexosamine residue on anticoagulant activity of fully O-sulfonated glycosaminoglycans.

Authors:  T Toida; A Suzuki; K Nakajima; A Chaidedgumjorn; T Imanari
Journal:  Glycoconj J       Date:  2000-06       Impact factor: 2.916

4.  Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance.

Authors:  Haining Yu; Eva M Muñoz; R Erik Edens; Robert J Linhardt
Journal:  Biochim Biophys Acta       Date:  2005-08-15

Review 5.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

6.  Low-molecular-weight sulfonated chitosan as template for anticoagulant nanoparticles.

Authors:  Katja Heise; Mathias Hobisch; Liviu Sacarescu; Uros Maver; Josefine Hobisch; Tobias Reichelt; Marija Sega; Steffen Fischer; Stefan Spirk
Journal:  Int J Nanomedicine       Date:  2018-08-30

Review 7.  Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.

Authors:  Masayuki Ishihara; Shingo Nakamura; Yoko Sato; Tomohiro Takayama; Koichi Fukuda; Masanori Fujita; Kaoru Murakami; Hidetaka Yokoe
Journal:  Molecules       Date:  2019-12-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.